Panels
Strategies for Global Access
Successes and challenges for payers and providers with EHR's, portability of personal data (Google Health, Microsoft HealthVault, etc), disruptive technologies, forces of consumerism in healthcare data, role in improving quality, reducing costs, who should pay for it.
Confirmed Panelists:
Moderator & Panelist Bios
Amy Kapczynski, Assistant Professor, Boalt School of Law, UC Berkeley
Ms. Kapczynski is an Assistant Professor at the UC Berkeley Boalt School of Law. She has clerked for the United States Court of Appeals
for the Second Circuit and the U.S. Supreme Court. Her current
research interests occupy the intersections between international law,
intellectual property, and global health. She received her J.D. from Yale Law.
Jana Armstrong, Director of Drugs, Neglected Diseases Initiative
Ms. Armstrong is the Director of Drugs for Neglected Diseases Initiative (DNDi) North America, and she has spent time with the
humanitarian medical relief agency Doctors Without Borders in Kenya, Sudan and Switzerland. Ms. Armstrong has an MBA in International
Management from Thunderbird/American Graduate School of International Management and a BS from Indiana University.
Melodie Holden, Chief Operating Officer and Senior Vice President, Venture Strategies for Health & Development
Ms. Holden is an engineer and economist who has worked extensively in Asia and Africa and is experienced in developing new business, as well as budgeting and evaluation. Her responsibilities for Venture Strategies, which is currently focused on reducing maternal mortality in African and South Asian countries, includes drug regulatory and distribution programs. She is applying business approaches to bringing low-cost, high-quality health technologies to developing countries at the request of governments. Ms. Holden is also faculty member of the School of Public Health at the University of California. She comes from seven years as an IBM consultant in business strategies.
Venkat Ramanan, Associate Director, Gilead Sciences
Mr. Ramanan is an Associate Director in the International Access
Operations at Gilead Sciences where he is responsible for managing
demand requirements and ensuring efficient supply of HIV drugs.
Previously, he worked at Amgen in the Global Supply Chain
Management function. Mr. Ramanan has a PhD in Mechanical
Engineering from the The Ohio State University.